SK282727B6 - 1,3-Disubstituované močoviny - inhibítory ACAT a spôsob ich prípravy - Google Patents

1,3-Disubstituované močoviny - inhibítory ACAT a spôsob ich prípravy Download PDF

Info

Publication number
SK282727B6
SK282727B6 SK1751-97A SK175197A SK282727B6 SK 282727 B6 SK282727 B6 SK 282727B6 SK 175197 A SK175197 A SK 175197A SK 282727 B6 SK282727 B6 SK 282727B6
Authority
SK
Slovakia
Prior art keywords
phenyl
dichlorophenyl
urea
yield
analysis
Prior art date
Application number
SK1751-97A
Other languages
English (en)
Slovak (sk)
Other versions
SK175197A3 (en
Inventor
Vladim�R Oremus
Vendel�N �Mahovsk�
Viera Faberov�
Ivan Kakal�K
�Udmila Schmidtov�
Mari�N Zem�Nek
Original Assignee
Slovakofarma, A. S.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Slovakofarma, A. S. filed Critical Slovakofarma, A. S.
Priority to SK1751-97A priority Critical patent/SK282727B6/sk
Priority to PT98961715T priority patent/PT1042278E/pt
Priority to US09/581,821 priority patent/US6444691B1/en
Priority to PCT/SK1998/000019 priority patent/WO1999032437A1/en
Priority to PL98341235A priority patent/PL341235A1/xx
Priority to HU0004332A priority patent/HUP0004332A3/hu
Priority to EP98961715A priority patent/EP1042278B1/en
Priority to ES98961715T priority patent/ES2194379T3/es
Priority to JP2000525374A priority patent/JP2001526259A/ja
Priority to DE69811949T priority patent/DE69811949T2/de
Priority to YU35100A priority patent/YU35100A/sh
Priority to SI9830419T priority patent/SI1042278T1/xx
Priority to RU2000119612/04A priority patent/RU2216536C2/ru
Priority to DK98961715T priority patent/DK1042278T3/da
Priority to CZ20002297A priority patent/CZ299695B6/cs
Priority to AT98961715T priority patent/ATE233727T1/de
Priority to AU16976/99A priority patent/AU1697699A/en
Publication of SK175197A3 publication Critical patent/SK175197A3/sk
Priority to HR20000351A priority patent/HRP20000351B1/xx
Priority to BG104537A priority patent/BG104537A/xx
Publication of SK282727B6 publication Critical patent/SK282727B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/32—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms
    • C07C275/34—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms having nitrogen atoms of urea groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C275/36—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms having nitrogen atoms of urea groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with at least one of the oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. N-aryloxyphenylureas
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
    • C07C323/43—Y being a hetero atom
    • C07C323/44—X or Y being nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Enzymes And Modification Thereof (AREA)
SK1751-97A 1997-12-19 1997-12-19 1,3-Disubstituované močoviny - inhibítory ACAT a spôsob ich prípravy SK282727B6 (sk)

Priority Applications (19)

Application Number Priority Date Filing Date Title
SK1751-97A SK282727B6 (sk) 1997-12-19 1997-12-19 1,3-Disubstituované močoviny - inhibítory ACAT a spôsob ich prípravy
DE69811949T DE69811949T2 (de) 1997-12-19 1998-12-16 1,3-disubstituierte harnstoffe als acat-inhibitoren, sowie verfahren zu deren herstellung
YU35100A YU35100A (sh) 1997-12-19 1998-12-16 1,3-disupstituisane uree kao inhibitori enzima holesterol aciltransferaze (acat), i postupak za njihovo dobijanje
PCT/SK1998/000019 WO1999032437A1 (en) 1997-12-19 1998-12-16 1,3-disubstituted ureas as acat inhibitors, and method of preparing thereof
PL98341235A PL341235A1 (en) 1997-12-19 1998-12-16 1,3-disubstituted ureas as inhibitors of acat and method of obtaining them
HU0004332A HUP0004332A3 (en) 1997-12-19 1998-12-16 1,3-disubstituted ureas as acat inhibitors, and method of preparing thereof
EP98961715A EP1042278B1 (en) 1997-12-19 1998-12-16 1,3-disubstituted ureas as acat inhibitors, and method of preparing thereof
ES98961715T ES2194379T3 (es) 1997-12-19 1998-12-16 Ureas 1,3-disustituidas como inhibidores de acat, y metodo de preparacion de las mismas.
JP2000525374A JP2001526259A (ja) 1997-12-19 1998-12-16 Ａｃａｔ阻害剤としての１，３位二置換尿素およびその製造法
PT98961715T PT1042278E (pt) 1997-12-19 1998-12-16 Ureias di-substituidas nas posicoes 1 e 3, utilizadas como inibidores de acat e o seu processo de preparacao
US09/581,821 US6444691B1 (en) 1997-12-19 1998-12-16 1,3-disubstituted ureas as ACAT inhibitors, and method of preparing thereof
SI9830419T SI1042278T1 (en) 1997-12-19 1998-12-16 1,3-disubstituted ureas as acat inhibitors, and method of preparing thereof
RU2000119612/04A RU2216536C2 (ru) 1997-12-19 1998-12-16 1,3-дизамещенные мочевины в качестве ингибиторов холестерол-ацилтрансферазы и способ их получения
DK98961715T DK1042278T3 (da) 1997-12-19 1998-12-16 1,3-disubstituerede urinstoffer som ACAT inhibitorer samt fremgangsmåde til fremstilling deraf
CZ20002297A CZ299695B6 (cs) 1997-12-19 1998-12-16 1,3-Disubstituované mocoviny jako inhibitory ACATa zpusob jejich prípravy
AT98961715T ATE233727T1 (de) 1997-12-19 1998-12-16 1,3-disubstituierte harnstoffe als acat- inhibitoren, sowie verfahren zu deren herstellung
AU16976/99A AU1697699A (en) 1997-12-19 1998-12-16 1,3-disubstituted ureas as acat inhibitors, and method of preparing thereof
HR20000351A HRP20000351B1 (en) 1997-12-19 2000-05-26 1,3-disubstituted ureas as acat inhibitors, and method of preparing thereof
BG104537A BG104537A (en) 1997-12-19 2000-06-15 1,3-doublesubstituted carbamides as acat inhibitors and method for their preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SK1751-97A SK282727B6 (sk) 1997-12-19 1997-12-19 1,3-Disubstituované močoviny - inhibítory ACAT a spôsob ich prípravy

Publications (2)

Publication Number Publication Date
SK175197A3 SK175197A3 (en) 1999-07-12
SK282727B6 true SK282727B6 (sk) 2002-11-06

Family

ID=20434795

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1751-97A SK282727B6 (sk) 1997-12-19 1997-12-19 1,3-Disubstituované močoviny - inhibítory ACAT a spôsob ich prípravy

Country Status (18)

Country Link
US (1) US6444691B1 (da)
EP (1) EP1042278B1 (da)
JP (1) JP2001526259A (da)
AT (1) ATE233727T1 (da)
AU (1) AU1697699A (da)
BG (1) BG104537A (da)
CZ (1) CZ299695B6 (da)
DE (1) DE69811949T2 (da)
DK (1) DK1042278T3 (da)
ES (1) ES2194379T3 (da)
HR (1) HRP20000351B1 (da)
HU (1) HUP0004332A3 (da)
PL (1) PL341235A1 (da)
PT (1) PT1042278E (da)
RU (1) RU2216536C2 (da)
SK (1) SK282727B6 (da)
WO (1) WO1999032437A1 (da)
YU (1) YU35100A (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2298311B1 (en) 1999-01-13 2012-05-09 Bayer HealthCare LLC w-Carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors
US7928239B2 (en) * 1999-01-13 2011-04-19 Bayer Healthcare Llc Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas
US8124630B2 (en) 1999-01-13 2012-02-28 Bayer Healthcare Llc ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
DK1580188T3 (da) 2002-02-11 2012-02-06 Bayer Healthcare Llc Forbindelser af arylurea som kinaseinhibitorer
WO2003068228A1 (en) 2002-02-11 2003-08-21 Bayer Pharmaceuticals Corporation Aryl ureas with angiogenesis inhibiting activity
UY28213A1 (es) 2003-02-28 2004-09-30 Bayer Pharmaceuticals Corp Nuevos derivados de cianopiridina útiles en el tratamiento de cáncer y otros trastornos.
AU2004228028B2 (en) 2003-04-03 2009-12-10 The Regents Of The University Of California Improved inhibitors for the soluble epoxide hydrolase
EP1636585B2 (en) 2003-05-20 2012-06-13 Bayer HealthCare LLC Diaryl ureas with kinase inhibiting activity
ME00294B (me) 2003-07-23 2011-05-10 Bayer Pharmaceuticals Corp Fluoro supstituisana omega-karaboksiaril difenil urea za liječenje i prevenciju bolesti i stanja bolesti
WO2005068420A1 (en) * 2003-12-23 2005-07-28 Esperion Therapeutics, Inc. Urea and thiourea compounds and compositions for cholesterol management and related uses
US20090018092A1 (en) 2004-03-16 2009-01-15 The Regents Of The University Of California Reducing Nephropathy with Inhibitors of Soluble Epoxide Hydrolase and Epoxyeicosanoids
US7662910B2 (en) * 2004-10-20 2010-02-16 The Regents Of The University Of California Inhibitors for the soluble epoxide hydrolase
SK287385B6 (sk) 2007-11-27 2010-08-09 Hameln-Rds, A. S. 1,3-Disubstituované močoviny, spôsob ich prípravy a použitia
HRP20090186A2 (hr) 2009-03-31 2010-10-31 Institut Ruđer Bošković Adamantanski bisureidni derivati, metoda priprave i primjena u detekciji aniona
US8912184B1 (en) 2010-03-01 2014-12-16 Alzheimer's Institute Of America, Inc. Therapeutic and diagnostic methods
WO2011109441A1 (en) * 2010-03-01 2011-09-09 Myrexis, Inc. Compounds and therapeutic uses thereof
RU2486893C1 (ru) * 2012-06-13 2013-07-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Волгоградский государственный технический университет" (ВолгГТУ) Способ получения бис[3-метил(адамант-1-ил)]мочевин
CN107417478B (zh) * 2017-06-05 2020-05-05 南京师范大学 一种催化氧化羰基化合成不对称二取代脲的方法
CN115677660B (zh) * 2022-10-27 2024-05-03 中国药科大学 苯基脲类化合物及其制备方法、用途和药物组合物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3284433A (en) * 1963-07-17 1966-11-08 Merck & Co Inc 4-phenoxy-carbanilides
FR1593586A (da) * 1967-10-17 1970-06-01
DE2246109A1 (de) * 1972-09-20 1974-03-28 Bayer Ag 1-(4-phenoxy-phenyl)-1,3,5-triazinderivate, ein verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
JP2720053B2 (ja) * 1988-11-09 1998-02-25 チッソ株式会社 新規なジアミノ化合物、ジニトロ化合物、ジオール化合物および製造方法
FR2674522B1 (fr) 1991-03-26 1993-07-16 Lipha Nouveaux derives de l'indole, procedes de preparation et medicaments les contenant.
JP3668266B2 (ja) 1994-02-01 2005-07-06 株式会社日清製粉グループ本社 尿素誘導体
US5576335A (en) 1994-02-01 1996-11-19 Nisshin Flour Milling Co., Ltd. Urea derivatives and their use as ACAT inhibitors
CA2161376C (en) * 1994-10-27 2005-01-11 Toshiaki Minami Reversible multi-color thermal recording medium

Also Published As

Publication number Publication date
YU35100A (sh) 2002-10-18
ATE233727T1 (de) 2003-03-15
DE69811949D1 (de) 2003-04-10
WO1999032437A1 (en) 1999-07-01
EP1042278A1 (en) 2000-10-11
DE69811949T2 (de) 2004-03-04
AU1697699A (en) 1999-07-12
HUP0004332A3 (en) 2002-11-28
RU2216536C2 (ru) 2003-11-20
HRP20000351B1 (en) 2003-10-31
PT1042278E (pt) 2003-07-31
CZ20002297A3 (cs) 2000-11-15
HRP20000351A2 (en) 2000-12-31
ES2194379T3 (es) 2003-11-16
JP2001526259A (ja) 2001-12-18
PL341235A1 (en) 2001-03-26
HUP0004332A2 (hu) 2001-05-28
EP1042278B1 (en) 2003-03-05
CZ299695B6 (cs) 2008-10-22
US6444691B1 (en) 2002-09-03
BG104537A (en) 2000-12-29
DK1042278T3 (da) 2003-06-30
SK175197A3 (en) 1999-07-12

Similar Documents

Publication Publication Date Title
SK282727B6 (sk) 1,3-Disubstituované močoviny - inhibítory ACAT a spôsob ich prípravy
EP1064274B1 (en) Benzenesulfonamide derivatives and their use as medicaments
US6048866A (en) Substituted 2-anilinopryimidines useful as protein kinase inhibitors
RU2183211C2 (ru) Производные 2-(иминометил)аминофенила, способ их получения, фармацевтическая композиция на их основе и промежуточные вещества
CA2423315A1 (en) Substituted amino-aza-cycloalkanes useful against malaria
Webber et al. Substituted 2-iminopiperidines as inhibitors of human nitric oxide synthase isoforms
Pavić et al. Novel semicarbazides and ureas of primaquine with bulky aryl or hydroxyalkyl substituents: Synthesis, cytostatic and antioxidative activity
JPH0741461A (ja) スルホン酸エステル誘導体
Clader et al. Substituted (1, 2-diarylethyl) amide acyl-CoA: cholesterol acyltransferase inhibitors: effect of polar groups on in vitro and in vivo activity
CZ280182B6 (cs) Terapeuticky účinné látky
EP0742208A1 (en) 2-Ureido-benzamide derivatives
KR20180030706A (ko) 용해성 에폭사이드 하이드롤라제 저해제로서 아다만틸우레아의 유사체
TW474931B (en) 3-amidochromanylsulfonyl(thio)ureas, processes for their preparation, their use, and pharmaceutical preparations comprising them
CA2468761A1 (en) Novel anticancer compounds
RU2260005C2 (ru) Производные липоевой кислоты, способ их получения (варианты) и фармацевтическая композиция
EP1187817B1 (en) Cathecol hydrazone derivatives, process for preparing the same and pharmaceutical composition containing the same
Abu Khalaf et al. Tryptophan and thiosemicarbazide derivatives: design, synthesis, and biological evaluation as potential β-d-galactosidase and β-d-glucosidase inhibitors
CZ279340B6 (cs) Hydrazony
US3539626A (en) Substituted urea derivatives
Buchman et al. Antihypertensive 5, 6-diarylpyridazin-3-ones
US5494922A (en) Allophanic acid derivatives
SG185411A1 (en) Modulators of fatty acid amide hydrolase
EP1761480B1 (en) Mao-b inhibitors
JPH0459754A (ja) アミド誘導体
Romeo et al. Synthesis of novel 4, 5-diphenylthiazole derivatives as potential acyl-CoA: cholesterol O-acyltransferase inhibitors